Skip to contentN
National Health Investors Inc
N
NHINational Health Investors Inc Q2 2025 · 10-Q
Revenue$14.22M$14.22M+6.2% vs Q2 2024 Net Income$36.99M$36.99M+4.9% vs Q2 2024 EPS Diluted$0.79$0.79−2.5% vs Q2 2024 Operating Cash Flowderived$59,817,000−1.5% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR
ended Jun 30, 2025 · filed Aug 6, 2025 · 37 d after period end